Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily. clinical trials

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

This study is looking at an experimental medicine called BMN 111 for children with achondroplasia. It's an extension of a previous study, checking how safe and effective the medicine is long-term until children stop growing.